» Articles » PMID: 24362051

Therapy-associated Polyposis As a Late Sequela of Cancer treatment

Overview
Specialty Gastroenterology
Date 2013 Dec 24
PMID 24362051
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Survivors of childhood cancers are at increased risk of developing secondary gastrointestinal cancers, including colorectal cancer, later in life, possibly from exposure to abdominopelvic radiotherapy and/or alkylating chemotherapy. Profuse gastrointestinal polyposis is associated with rare, inherited colorectal cancer predisposition syndromes, most commonly caused by mutations in the adenomatous polyposis coli (APC) or mutY homolog (MUTYH) genes. We describe 5 patients who developed gastrointestinal polyposis many years after radiotherapy and chemotherapy for a childhood cancer. Genetic analysis of all 5 subjects did not identify pathogenic germline mutations in APC or MUTYH. Chemotherapy and/or radiotherapy therefore might cause gastrointestinal polyposis in some patients by undiscovered mechanisms.

Citing Articles

Therapy-Associated Polyposis, Late Presentation of a Childhood-Treated Disease.

McGarrity T, Aynardi J, Peiffer L, Ashktorab H, Razjouyan H ACG Case Rep J. 2024; 11(6):e01379.

PMID: 38883581 PMC: 11177831. DOI: 10.14309/crj.0000000000001379.


Curative resection via right hemicolectomy and regional lymph node dissection for colonic adenomatous polyposis of unknown etiology with adenocarcinomas localized in the right side of the colon: a case report.

Aoyama S, Inoue A, Kagawa Y, Komori T, Ozato Y, Nishizawa Y Surg Case Rep. 2024; 10(1):93.

PMID: 38647838 PMC: 11035501. DOI: 10.1186/s40792-024-01890-1.


Yield of upper gastrointestinal screening in colonic adenomatous polyposis of unknown etiology: a multicenter study.

Farah F, Patel S, Espinoza J, Jensen N, Katona B, Muller C Endosc Int Open. 2022; 10(4):E528-E533.

PMID: 35433207 PMC: 9010079. DOI: 10.1055/a-1784-0166.


How many is too many? Polyposis syndromes and what to do next.

Gupta N, Drogan C, Kupfer S Curr Opin Gastroenterol. 2021; 38(1):39-47.

PMID: 34839308 PMC: 8648991. DOI: 10.1097/MOG.0000000000000796.


A Multi-Institutional Cohort of Therapy-Associated Polyposis in Childhood and Young Adulthood Cancer Survivors.

Biller L, Ukaegbu C, Dhingra T, Burke C, Chertock Y, Chittenden A Cancer Prev Res (Phila). 2020; 13(3):291-298.

PMID: 32051178 PMC: 7060102. DOI: 10.1158/1940-6207.CAPR-19-0416.


References
1.
Swerdlow A, Barber J, Hudson G, Cunningham D, Gupta R, Hancock B . Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol. 2000; 18(3):498-509. DOI: 10.1200/JCO.2000.18.3.498. View

2.
Cheah P, Wong Y, Chau Y, Loi C, Lim K, Lim J . Germline bone morphogenesis protein receptor 1A mutation causes colorectal tumorigenesis in hereditary mixed polyposis syndrome. Am J Gastroenterol. 2009; 104(12):3027-33. DOI: 10.1038/ajg.2009.542. View

3.
Morton L, Dores G, Curtis R, Lynch C, Stovall M, Hall P . Stomach cancer risk after treatment for hodgkin lymphoma. J Clin Oncol. 2013; 31(27):3369-77. PMC: 3770865. DOI: 10.1200/JCO.2013.50.6832. View

4.
Vogt S, Jones N, Christian D, Engel C, Nielsen M, Kaufmann A . Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology. 2009; 137(6):1976-85.e1-10. DOI: 10.1053/j.gastro.2009.08.052. View

5.
Reulen R, Frobisher C, Winter D, Kelly J, Lancashire E, Stiller C . Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA. 2011; 305(22):2311-9. DOI: 10.1001/jama.2011.747. View